Memphis Man's Canoodling Goes Wrong After Getting Shot By His Dog

1 The man in memphisThe morning morning made a strange and painful turn when he insisted on him. dog He accidentally shot him while he was in bed.

Although dogs are known for their loyalty, this strange incident shows that even human best friends can have a break, especially when firearms are involved.

Another story about dogs is that science is working on how to make your furry friends stick longer. In 2023, a groundbreaking drug designed to extend dog life expectancy hit a major milestone with FDA approval.

The unique incident unfolded just before 4am on Whitney Avenue when police responded to reports of an accidental shooting. Victim Gerald Kirkwood told officials he was lying in bed with a fellow female pit bull Oreo, who was suddenly jumping into bed.

It is said that in an unusual accident the dog stepped into the trigger guard of a firearm. The bullet grazes Kirkwood’s left thigh, causing life-threatening injuries.

Wreg reports that Kirkwood was transported to local people in a non-critical state. Meanwhile, the victim’s friend argued that Oreo was a friendly dog ​​and that the entire situation was nothing more than an unfortunate accident.

A female companion from Kirkwood, who has already given another twist to the strange case, reportedly fled the scene after the shooting.

Despite the risks of pet ownership, dog lovers may soon have a way to extend the lives of their furry companions as groundbreaking anti-aging drugs approach approval.

Loyal, a biotechnology company focused on extending PET lifespan, announced in 2023 that a conditional approval application for LOY-001 had passed a significant regulatory milestone at the FDA veterinary center.

BLAST reported that FDA conditional approval was based on data provided by Loyal. This demonstrated the ability of drugs to lower levels of IGF-1, an important biomarker associated with aging, and the potential to improve functional outcomes in dogs.

Although still in development at the time, the Loy-001 is designed specifically for larger breeds that tend to have a shorter lifespan than small dogs.

New medications designed for healthy dogs over 7 years old weighing over 40 pounds are administered by the veterinarian every 3-6 months.

Although it has not yet undergone clinical trials, its approval marks an important milestone, indicating the first potential approval of the FDA’s longevity drug.

Loyal, the biotechnology company behind drugs, sees it as a step towards revolutionizing pet health. Speaking about the results, CEO Serin Hario told Business Wire.

“The Royal was founded with an ambitious goal of developing the first drug to extend the healthy lifespan of a dog, and this milestone is the result of years of careful work by the team.

The groundbreaking drugs are making waves in the veterinary world, and industry experts have honoured it as a historic achievement. Linda Rhodes, a drug development expert with respected animal health and seasoning, praised the milestone. In her words:

“The Royal’s achievements are impressive. Developing treatments that will increase lifespan by reducing age-related diseases is a new indication. Approved Such claims and development of new indications through regulatory bodies requires great rigor and persistence. It is truly historic to have brought treatment for such rewarding signs to the beginning. ”

This recognition follows years of dedicated research and significant financial boost. Loyal reportedly secured $27 million in the Series A funding round led by Khosla Ventures.

The investment also saw donations from Box Group, First Round Capital, The Longevity Fund, Collaborative Fund and Lachy Groom.

Another pressing concern emerged when the dog owner celebrated a potential breakthrough.

Veterinarians issued urgent warnings about unidentified respiratory illnesses affecting pets. They noted that affected dogs exhibited surprising symptoms, including persistent cough, nose or eye discharge, and lethargy.

Amanda Cabana, director of emergency care services at Colorado State University Veterinary Teaching Hospital, described the changes in symptoms, saying, “It was this wet cough that made the dog sick, instead of that dry cough that made the dog feel better.”

The dog shooting is a strange reminder of how pet ownership is rewarded and there are truly unexpected risks.